Product description

The geneMAP™ BCR-ABL1 p210 IS-MMR Kit is intended for the quantitative detection of BCR-ABL1 p210 b2a2 and b3a2 fusion transcripts in bone marrow or peripheral blood samples of patients who have been diagnosed with Acute Lymphoblastic Leukemia (ALL) or Chronic Myeloid Leukemia (CML). This test can be used to monitor Minimal Residual Disease (MRD) in patients undergoing therapy.

Size: 48 tests

Features

• Quantitative determination of BCR-ABL1 fusion gene b3a2(e14a2) and b2a2(e13a2) transcripts.
• Ultra Sensitive: LOG 5 (NCN-IS %: 0.001) detection of BCR-ABL1 transcript.
• Fast and Easy to use with One Step RT-qPCR technology.International Scale results (IS-MMR).
• Primer probe mix, target gene and reference gene (ABL) are all in one tube (MULTIPLEX)
• ABL1 as a reference gene.
• Six standards for quantitation.
• Automatic analysis with geneMAP™ viewer (for CFX96™ / BIO-RAD)
• CE-IVD
• Real-time PCR

Related Products

geneMAP™MPL W515A/L/K/R Mutation Detection Kit

The geneMAP™ MPL W515A/L/K/R-S Detection Kit is intended for the detection of MPL exon 10 mutations in DNA extracted from peripheral blood. Size: 25...

geneMAP™ CALR Mutation Screening Kit

The geneMAP™ CALR Screening Kit is a qualitative in vitro assay for the detection of 36 CALR somatic mutations from human genomic DNA of subjects su...

geneMAP™ BCR-ABL1 (p190, p210, p230) Screening Kit

The geneMAP™ BCR-ABL1 Screening Kit is intended for detection of p190BCR-ABL1 (e1a2), p210BCR-ABL1 (b2a2 & b3a2) and p230BCR-ABL1 (e19a2) fusion...

geneMAP™ JAK-2 Exon 12 Mutations Detection Kit

Approximately 95% of Polycythemia Vera patients are positive for JAK2 mutation (exon 14) and only 5% are positive for JAK2 exon 12 mutation. JAK2 and ...